Abstract:In the late 1960s, ultrafiltration was first used in clinical settings to increase, by convection, the clearance of toxic solutes in patients undergoing dialysis. Unfortunately, the efficiency of convection-based dialysis treatment, or hemofiltration (HF), was limited by the relatively low ultrafiltration coefficient of the dialyzers available at the time. Thus, the exchanged volume was low, and the corresponding clearance of low-molecular-weight solutes was insufficient with respect to the current target value of Kt/V urea. This was probably the cause of the failed improvement in the clinical and metabolic status of patients compared with standard dialysis treatment. In 1977, favorable results of the combination of diffusion and convection demonstrated the potential advantage of hemodiafiltration (HDF) over HF in terms of dialysis clearance. HDF was in fact the only means to obtain significant clearance of high-molecular-weight solutes while maintaining adequate urea clearance, whereas the increase in mean hematocrit in the erythropoietin era limited the exchanged volume in HF, in spite of the improved water permeability of the dialysis membranes. Mixed diffusive and convective clearance is less than the sum of the two parts because of reciprocal interference. Diffusive clearance mainly depends on the membrane permeability and the solute concentration gradient. New, highly permeable dialysis membranes can reach significant clearance of high-molecular-weight solutes such as Beta2 microglobulin (B2m) simply by diffusion, although in clinical settings there is also considerable ''hidden'' convection due to backfiltration. However, convection remains the best way to remove high-molecular-weight solutes, also for this kind of membrane. The ultrafiltration rate and the sieving coefficient account for the amount of convective clearance, as described in detail in the text. To define the treatment dose, the equation of Waniewsky allows the theoretical calculation of the urea clearance in HDF, both in postdilution and predilution mode. Unfortunately, no such equation is available for B2m. With a new mathematical model, well fitting with preliminary measured data although not fully validated, we calculated the relationship between urea and B2m clearance in predilution versus postdilution HDF, also considering the impact of variables such as blood and ultrafiltration flow. In particular, the predilution mode may decrease the urea clearance in comparison to hemodialysis with the same membrane and blood flow. This also applies to B2m clearance in predilution vs postdilution HDF, in spite of a marked increase in the ultrafiltration rate, at least in the more common clinical settings. In conclusion, good knowledge of the physics of solute transport is mandatory for appropriate prescription of HDF, in order to maximize both low- and high-molecular-weight solute clearance.

Removal of β2-microglobulin during on-line hemodiafiltration using a domestic hemofilter

Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins

High-flux Hemodialysis Efficiently Removes Β_2-Microglobin and Improves Inflammation Status in Maintain Hemodialysis Patients

Evaluation of Safety and Effectiveness of Domestically Produced High-Flux Dialyzer for Hemodialysis Patients

The solutes removal capability in four different membrane dialyzers in hemodialysis maintenance patients

Actually Delivered Dose of Continuous Renal Replacement Therapy is Underestimated in Hemofiltration.

A Comparative Study of the Performance of High-Flux Versus Low-Flux Hemodialysis

Depurative capacity toward medium molecules of the dialyzer Toray NV-U® Hydrolink™: A new hydrophilic membrane to perform online hemodiafiltration

Effects of filter reuse on solute clearance and safety in on-line hemodiafiltration

Depurative capacity toward medium molecules of the dialyzer Toray NV-U® HydrolinkTM: A new hydrophilic membrane to perform online hemodiafiltration

The short-term clinical effects of super-high flux hemodialysis on refractory complications in maintenance hemodialysis patients

New modes of continuous renal replacement therapy using a refiltering technique to reduce micronutrient loss

Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial

Hirudin elimination by hemofiltration: a comparative in vitro study of different membranes

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

Removal of Iron Dextran During Hemodialysis with Polysulfone F6 and Homophone GFSplus12

Upgrade of dialysate quality improves the microinflammation in maintenance haemodialysis patients

[Evolution and physical principles of convection-based dialysis treatment]

Effects of Extracorporeal Blood Flow Rates on Patient Tolerance for LIXELLE ® Treatment during Outpatient Hemodialysis

Online Hemodiafiltration: A New Perspective for Patients With End-Stage Renal Disease

Preliminary Examination on Removal of Protein-Bound Toxins by Hemolipodialysis